Psyence Biomedical (PBM) Share-based Compensation (2023)
Psyence Biomedical (PBM) posted Share-based Compensation of $1.4 million for Q3 2023, down 100.0% on a QoQ basis from $221.3 billion in Q1 2023.
Powered by 
Analysis
Psyence Biomedical (PBM) Share-based Compensation (2023) Analysis & Trends
Psyence Biomedical has reported Share-based Compensation for 1 years, with the latest figure at $1.4 million in Q3 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 207.47 Bn | 193.48 Bn | 7.24 Bn | 247.00 Mn |
| 2 | Gilead Sciences | 178.76 Bn | 175.58 Bn | 6.22 Bn | 231.00 Mn |
| 3 | Vertex Pharmaceuticals | 131.52 Bn | 123.67 Bn | 2.84 Bn | 108.10 Mn |
| 4 | Regeneron Pharmaceuticals | 81.91 Bn | 73.91 Bn | 3.93 Bn | 243.00 Mn |
| 5 | Argenx Se | 61.10 Bn | 55.91 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.44 Bn | 48.30 Bn | 52.00 Mn | 120.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.55 Bn | 30.24 Bn | 992.69 Mn | 86.63 Mn |
| 8 | Biogen | 31.67 Bn | 30.39 Bn | 1.96 Bn | 77.40 Mn |
| 9 | Roivant Sciences | 29.63 Bn | 29.63 Bn | 1.16 Mn | 83.34 Mn |
| 10 | Psyence Biomedical | 2.63 Mn | 2.63 Mn | - | - |